 In an interview, Chief Financial Officer Robin Kramer said the combined cash flow from Biogen and Apellis will not only help debt leverage ratios but also free up capacity to do other strategic deals. 
Content mobilized by FeedBlitz RSS Services, the premium FeedBurner alternative. |
